You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 6, June 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neovascular Glaucoma After Photoradiation Therapy for Uveal Melanoma

Richard A. Lewis, MD; David T. Tse, MD; Charles D. Phelps, MD; Thomas A. Weingeist, PhD, MD

Arch Ophthalmol. 1984;102(6):839-842.


Abstract

• We describe two patients (two eyes) with neovascular glaucoma following photoradiation therapy (PRT) for ciliary body and iris melanoma. Histopathologic examination in one eye eight months after treatment disclosed widespread tumor necrosis. The second patient with iris melanoma showed total clinical disappearance of the lesion and regression of iris neovascularization six months later. The cause of the neovascular glaucoma is uncertain. The marked tumor necrosis induced by PRT might have resulted in release of a vasoproliferative factor that, in turn, led to the development of rubeosis and neovascular glaucoma.



Author Affiliations

From the Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City. Dr Lewis was a fellow of the Heed Foundation; he is now with the University of California-Davis.


Footnotes

Accepted for publication Dec 5, 1983.

Reprint requests to the Department of Ophthalmology, University of Iowa Hospitals, Iowa City, IA 52242 (Dr Tse).

This investigation was funded in part by support grant RR 05372 from the Biomedical Research Support Branch, Division of Research Facilities and Resources, National Institutes of Health (Dr Tse) and by grant IN-122C from the American Cancer Society (Dr Tse).

Vernon Hermsen, MD, and Karl Ossoinig, MD, performed the ultrasound evaluations and interpretations.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hematoporphyrin Photoradiation Therapy for Intraocular and Orbital Malignant Melanoma
Tse et al.
Arch Ophthalmol 1984;102:833-838.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.